Back | Next |
home / stock / gnpx / gnpx message board
Subject | By | Source | When |
---|---|---|---|
Looking like another low volume manipulation pump day. | trendzone | investorshub | 01/12/2022 5:56:56 PM |
Looking good | europtiger | investorshub | 01/11/2022 6:36:12 PM |
2,28 back in | europtiger | investorshub | 01/11/2022 5:32:32 PM |
Pls go all the way back in my | europtiger | investorshub | 01/11/2022 5:31:43 PM |
whytestocks: $GNPX News Article - InvestorNewsBreaks - Genprex Inc. (NASDAQ: GNPX) to Accelerate Ope | whytestocks | investorshangout | 01/10/2022 6:15:48 PM |
With still being over bought, it could be | trendzone | investorshub | 01/06/2022 3:14:54 PM |
Dark Red | howardriggin | investorshub | 01/05/2022 3:49:42 PM |
Fake Investors of $GNPX, since the DD has | laraz5 | investorshub | 01/05/2022 2:25:39 PM |
Who wants to bet if today a green | J2003 | investorshub | 01/05/2022 1:12:08 PM |
Tomorrow sounds like round 2 for a run | J2003 | investorshub | 01/04/2022 8:48:46 PM |
Man, you sound angry | maximumgriff | investorshub | 01/04/2022 8:14:17 PM |
Tomorrow we may have another runwait to see | J2003 | investorshub | 01/04/2022 6:03:10 PM |
Complete Bullshit! You were not? $IMO | laraz5 | investorshub | 01/04/2022 5:14:40 PM |
Not in I was in the run a | europtiger | investorshub | 01/04/2022 4:37:53 PM |
Yeah better wait for opening bell | europtiger | investorshub | 01/04/2022 1:25:38 PM |
I rode this yesterday after-hours to $4.00 | Pedro2004 | investorshub | 01/04/2022 1:24:59 PM |
I just follow directors from bankruptcy to bankruptcy | laraz5 | investorshub | 01/04/2022 1:16:19 PM |
I hope not but it did look a | europtiger | investorshub | 01/04/2022 1:13:16 PM |
I was trying to figure-out where the shares | Pedro2004 | investorshub | 01/04/2022 1:11:50 PM |
Why you spend so much time ragging this | maximumgriff | investorshub | 01/04/2022 1:10:36 PM |
News, Short Squeeze, Breakout and More Instantly...
Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner PR Newswire Ryan Confer Appointed Genprex President and CEO and to its Board of Directors AUSTIN, Texas , May 8, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" o...
Genprex (NASDAQ: GNPX) , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, will be participating at two conferences during May. According to the announcement, Genprex CFO Ryan Confer will be presenting at the Sidoti Microcap...
Genprex to Present and Participate at Upcoming May Investor and Industry Conferences PR Newswire AUSTIN, Texas , May. 1, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developin...